Peer-reviewed veterinary case report
Human interferonalpha-2b shows limited benefit for dog skin infection
By Thompson, Lori A et al.·Published in Veterinary therapeutics : research in applied veterinary medicine·2004·Animal Allergy and Skin Disease Center, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Human recombinant interferonalpha-2b for management of idiopathic recurrent superficial pyoderma in dogs: a pilot study.
- Species:
- dog
Plain-English summary
A group of dogs with recurrent skin infections (idiopathic recurrent superficial pyoderma) was given a medication called human recombinant interferon-alpha-2b to see if it would help. While some dogs showed a temporary improvement, the treatment didn't work significantly better than a placebo. More research is needed to find out if this medication could be effective for long-term management of skin problems in dogs.
People also search for: dog skin infection treatment · recurrent pyoderma in dogs · interferon for dog skin problems
Abstract
The oral use of human recombinant interferonalpha-2b at 1,000 IU/ml/day appeared to provide only a transient benefit as compared with placebo for management of idiopathic recurrent superficial pyoderma in dogs. Further investigation using a larger population of dogs is needed to determine whether interferon is effective for long-term treatment of this condition.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/15150732/